Plasma vitamin D levels at birth and immune status of preterm infants

Florentina Sava1, András Treszl2, Júlia Hajdú1

  • 1First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary.

Immunobiology
|June 20, 2016
PubMed

Insights

Vitamin D levels at birth influence immune cell subsets in preterm infants. Lower vitamin D was linked to higher Th1 cells and lower Th2 cells and plasmacytoid dendritic cells (pDCs).

Area of Science:

  • Immunology
  • Neonatology
  • Endocrinology

Background:

  • Vitamin D plays a crucial role in immune system modulation.
  • Understanding its impact on preterm infants is vital due to their immature immune systems.

Purpose of the Study:

  • To investigate the association between cord blood vitamin D levels and immune status in preterm infants.
  • To explore the influence of vitamin D on specific immune cell subsets and their balance.

Main Methods:

  • Cord blood samples from 28 preterm infants (≤30 weeks gestation) were analyzed.
  • Immune cell subsets (Th1, Th2, pDCs) and plasma cortisol/cytokine levels were measured using flow cytometry.
  • Statistical analysis used a mixed-effects model to assess the impact of vitamin D, cortisol, and gestational age.

Main Results:

  • Infants with lower vitamin D levels showed increased CD4+ CXCR3+ (Th1) and CD8+ CXCR3+ cells.
  • Lower vitamin D was associated with decreased CD4+ CCR4+ (Th2), CD8+ CCR4+, and plasmacytoid dendritic cells (pDCs).
  • Plasmacytoid dendritic cells and Th2 lymphocytes were uniquely influenced by vitamin D levels, independent of cortisol and gestational age.

Conclusions:

  • Vitamin D levels at birth may influence the Th1/Th2 balance in preterm newborns.
  • Vitamin D, along with cortisol and gestational age, could affect the prevalence of plasmacytoid dendritic cells.
  • Further research is needed to clarify the role of vitamin D in preterm infant immunity.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
647
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
693